License Agreement

OptiBiotix Health PLC – License agreement for LPLDL® in Japan

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular diseaseand diabetes, announces that its fully-owned subsidiary ProBiotix Health Ltd., has signed a non-exclusive license agreement with Tenshindo, Co. Ltd. for the use of Lactobacillus plantarum LPLDL® ("LPLDL®") in...

Read More

OptiBiotix Health PLC – License agreement for LPLDL®

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular diseaseand diabetes, announces that its fully-owned subsidiary ProBiotix Health Ltd., has signed a license agreement with Nutrilinea Srl. for the use of LPLDL® in a food supplement for the...

Read More